SCHEMBL25650053

SCHEMBL25650053

Cc1ccc(NCCN)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STK17A Q9UEE5 3/20 0.42
▸ KCNQ3 O43525 1/20 0.42
▸ KCNQ2 O43526 1/20 0.42
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2E1 P05181 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ ZAP70 P43403 1/20 0.39
▸ SYK P43405 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ FERMT2 Q96AC1 1/20 0.37
▸ SLC22A12 Q96S37 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CHEK1 O14757 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12697198 0.82 RRM2 (0.46) KCNQ3KCNQ2HDAC1HDAC8HDAC6
SCHEMBL9347587 0.81 NPSR1 (0.40) KCNQ3KCNQ2HDAC1HDAC8HDAC6
SCHEMBL20037762 0.81 MAPT (0.43) STK17AKCNQ3KCNQ2CYP1A2CYP2C19
SCHEMBL1074469 0.80 STK17A (0.40) STK17AHDAC1ZAP70SYKMAPT
SCHEMBL14197601 0.79 RRM2 (0.48) KCNQ3KCNQ2HDAC1HDAC8HDAC6
SCHEMBL12788678 0.78 SLC22A12 (0.41) KCNQ3KCNQ2HDAC1HDAC8HDAC6
SCHEMBL3632606 0.78 ADRA2A (0.50) KCNQ3KCNQ2HDAC1HDAC8HDAC6
SCHEMBL9220618 0.77 STK17A (0.44) STK17AKCNQ3KCNQ2MAPTGAA
SCHEMBL4574251 0.77 KMT2A (0.53) HDAC1HDAC8HDAC6MAPTNPSR1
SCHEMBL18386498 0.77 KCNH3 (0.48) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback